Nazanin Alaei Faradonbeh - General Physician, Medical Faculty, Islamic Azad University of Najafabad, Isfahan, Iran
Fariborz Nikaeen - Associate professor, Department of Cardiology, Medical faculty, Islamic Azad University of Najafabad, Isfahan, Iran
Mojtaba Akbari - Epidemiologist(PhD), deputy of research, Isfahan University of Medical Science, Isfahan, Iran
Naser Almasi - Doctor of Laboratory science, Central laboratory of Shariati hospital, Isfahan, Iran

Background: Cardiovascular diseases (CVDs) are the leading cause of death in most countries. Diabetic patients have a greater risk for CVDs. The aim of this study was to assess the prevalence and range of major CVDs risk factors among diabetic patients that received preventive and curative treatment at diabetes clinic of Shariati hospital based on gender and age.Methods: 418 diabetic participants aged 30-74 years old entered to this cross sectional study. Information about smoking habits, blood pressure, presence/absence of being under hypertension treatment and lipid profile were collected from each patient s medical record and SPSS version 20 was used for data analysis.Results: The mean age of participants was 59.8 years. Smoking prevalence was 4.3%. Mean blood pressure was 121.5/79.2 mmHg. Mean total cholesterol: 152.2 mg/dl, LDL-cholesterol: 83.1mg/dl, HDL- cholesterol: 45.4 mg/dl, non-HDL cholesterol: 106.7 mg/dl. The prevalence of normal LDL was 87.3% of men and 77.4% of women (P= 0.01). Women had abnormal HDL levels more frequently than men (60.3% vs. 45.2%, P= 0.002). Most non-HDL levels were in normal spectrum (90.4% of males vs. 79.8% of females, P= 0.04). In age group older than 65-year, normal values were more than abnormal except for female s HDL.Conclusions: the results showed that most of patients had normal ranges for CVDs risk factors and more attention for HDL control is needed. Multiple supplementary prospective studies must have been done to investigate the exact situation of risk factors range among diabetic patients that receive preventive and curative treatment for CVD reduction.

cardiovascular diseases, prevalence, diabetes mellitus, risk factor, prevention